Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy.
Doxorubicin remains one of the most widely used chemotherapeutic agents however its effect on healthy tissue, such as skeletal muscle, remains poorly understood. The purpose of the current study was to examine the accumulation of doxorubicin (DOX) and its metabolite doxorubicinol (DOXol) in skeletal...
Main Authors: | Sergio Fabris, David A MacLean |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4581622?pdf=render |
Similar Items
-
Doxorubicin chemotherapy affects the intracellular and interstitial free amino acid pools in skeletal muscle.
by: Sergio Fabris, et al.
Published: (2018-01-01) -
Doxorubicin induces inflammatory modulation and metabolic dysregulation in diabetic skeletal muscle
by: Rashmi Supriya, et al.
Published: (2016-07-01) -
The Potential of Stem Cells in the Treatment of Skeletal Muscle Injury and Disease
by: S. MacLean, et al.
Published: (2012-01-01) -
Expression of androgen receptor target genes in skeletal muscle
by: Kesha Rana, et al.
Published: (2014-10-01) -
MAL Inhibits the Production of HIV-1 Particles by Sequestering Gag to Intracellular Endosomal Compartments
by: Kei Miyakawa, et al.
Published: (2022-03-01)